Steve Street has joined Covance as global vice president and general manager to oversee the firm’s worldwide safety assessment and pharmaceutical chemistry services. He will be based in Harrogate, UK.
Street, with more than 27 years of experience in biopharmaceutical r&d, joins Covance from Pfizer, where he was vp and head of two global r&d units. Street also served as head of Pfizer’s Worldwide Chemistry Discipline.
Street commented: ‘Covance is known for its continuous global innovation in development, quality of products and services, and long-standing client relationships, all of which are essential elements for sustained success in today’s highly competitive r&d landscape.
‘With an increasing focus on outsourcing, this is a very exciting time to transition from pharma to a contract research organisation, and I am proud to join the industry leader.’
Covance, headquartered in Princeton, New Jersey, is a drug development services specialist.